References
Barrett BJ and Parfrey PS (2006) Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379–386
Aspelin P et al. (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491–499
Barrett BJ et al. (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double blind comparison of iodixanol and iopamidol. Invest Radiol 41: 815–821
Jo SH et al. (2006) Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48: 924–930
Pannu N et al. (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295: 2765–2779
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has received a consulting fee and speaker's honoraria from GE Medical.
Rights and permissions
About this article
Cite this article
Murray, P. Risk of contrast-induced nephropathy in patients with normal renal function: iso-osmolar versus low-osmolar medium. Nat Rev Nephrol 3, 306–307 (2007). https://doi.org/10.1038/ncpneph0490
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0490
- Springer Nature Limited